November 6, 2008 Remembering Our Siblings

Remembering our siblings -

1st Guest: Ruby Rose Fox was a bone marrow donor to her sister Dalia who died of Leukemia in 1992.  She is a Boston based actor, trained solo-performer, of “Little Legacy” a solo performance about a family’s journey through bereavement.

rubyfx@yahoo.com

2nd Guest:  Frank R. Lewis
Dr. Frank R. Lewis lost his brother  Dean, in an automobile accident in 1983. He led a sibling support group of The Compassionate Friends for 10 years and was a keynote speaker at Compassionate Friends National Conference in Nashville Tenesee where he is a Senior Pastor of the First Baptist Church.

Gardasil(R) Vaccine Honoured With International Galien Prize For Pharmaceutical Research

Gardasil®, the four-type (6,11,16,18) human papillomavirus (HPV) vaccine, has been awarded the 2008 International Galien Prize, a prestigious award for recognising and promoting significant advances in pharmaceutical research which is considered the pharmaceutical industry equivalent of the Nobel Prize. "It is gratifying to be part of the transformation of scientific breakthrough into actual benefits for people's health," says Didier Hoch, President of Sanofi Pasteur MSD.

Identification Of Mechanism, Possible Drug Treatment For Tumors In Neurofibromatosis

Researchers studying neurofibromatosis type 1 - a rare disease in which tumors grow within nerves - have found that the tumors are triggered by crosstalk between cells in the nerves and cells in the blood. The researchers, who were funded by the National Institutes of Health (NIH) and the Department of Defense (DOD), also found that a drug on the market for treating certain kinds of blood cancer curbs tumor growth in a mouse model of neurofibromatosis type 1.

Biothera To Present Imprime PGG(R) Clinical Trial Results At The International Society For Biological Therapy Of Cancer

Biothera will present the results of two separate Phase I clinical trials evaluating the safety of Imprime PGG®, the company's developmental immunotherapy cancer drug, at the International Society for Biological Therapy of Cancer on Saturday, November 1 in San Diego, Calif. Biothera has completed two randomized, double-blind, placebo-controlled clinical studies in a total of 36 healthy volunteers.

ERBITUX® Supplemental Biologics License Application For First-Line Recurrent Or Metastatic Head And Neck Cancer Accepted For Priority Review By FD

ImClone Systems Incorporated (NASDAQ: IMCL) and Bristol-Myers Squibb Company (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing and review the companies' supplemental Biologics License Application (sBLA) to broaden the indication for ERBITUX® (cetuximab) to include use in combination with platinum-based chemotherapy for the first-line treatment of patients with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN).

‘New’ Estrogen Receptor Found To Be Key Player In Tamoxifen Resistance

Researchers at Georgetown University Medical Center have discovered a novel way in which breast cancer cells become resistant to tamoxifen, the world's largest-selling breast cancer prevention and treatment drug. They say the findings could provide a way to identify tamoxifen users who are no longer benefiting from the drug, allowing doctors to try another therapy option sooner.

Aetna Tackles Quality Issues In Genetic Testing For Breast Cancer - Promoting Evidence-based Approach

Aetna (NYSE:AET) is implementing a comprehensive plan to increase the quality of genetic diagnosis and treatment of breast cancer. The company is guiding members and physicians to laboratories that meet national guidelines for genetic testing accuracy. Aetna also is funding research to understand the use of genetic tests in breast cancer treatment.

A Key To Aggressive Breast Cancer Discovered By UC Davis Researchers

In trying to find out why HER2-positive breast cancer can be more aggressive than other forms of the disease, UC Davis Cancer Center researchers have surprisingly discovered that HER2 itself is the culprit. By shutting down its own regulator gene, HER2 creates a permissive environment for tumor growth.

Oral Rinses Used For Tracking HPV-Positive Head And Neck Cancers Hold Promise For Screening

A study published in the journal Clinical Cancer Research, a journal of the American Association for Cancer Research, validates a non-invasive screening method with future potential for detection of human papillomavirus (HPV)-positive head and neck cancers.

Nutrition Advice For Cancer Patients And Survivors Available In New DVD

Good nutrition is vitally important to both cancer patients and cancer survivors in promoting healing and preventing recurrence. Yet this can be a challenge, especially for current patients, for whom eating and drinking is often difficult due to treatment side effects that alter appetite and sense of taste.

Next Page »